First, to further establish the relevance of PKM as a marker of the early glycolytic shift in AD, we analyzed the relationship of CSF PKM levels with cognitive decline in a proteomics dataset previously published by Tijms et al. [2]. Here, PKM is linked to Alzheimer disease.